Management of Immune-Related Adverse Events Guideline
ASCO Guidelines14 Feb 2018

Management of Immune-Related Adverse Events Guideline

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at www.asco.org/supportive-care-guidelines

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(195)

Systemic Treatment of Thyroid Cancer Guideline

Systemic Treatment of Thyroid Cancer Guideline

Dr. Nabil Saba shares the first evidence-based guideline on thyroid cancer from ASCO. He highlights recommendations on first- and subsequent-line systemic treatment – including multikinase inhibitors ...

1 Apr 23min

Patient-Clinician Communication Guideline Update

Patient-Clinician Communication Guideline Update

Dr. Timothy Gilligan and Dr. Calvin Chou discuss the updated guideline on patient-clinician communication in oncology. They highlight clinical recommendations and strategies on topics such as communic...

10 Mars 31min

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update

Dr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or metastatic gastroesophagea...

26 Feb 28min

White Blood Cell Growth Factors Guideline Update

White Blood Cell Growth Factors Guideline Update

Dr. Bishal Gyawali and Dr. Tessa Cigler share the new, comprehensive, evidence-based update of the ASCO guideline on the use of hematopoietic colony-stimulating factors in patients with cancer. They d...

25 Feb 23min

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2

Dr. Sonam Puri discusses the full update to the living guideline on stage IV NSCLC with driver alterations. She shares a new overarching recommendation on biomarking testing and explains the new recom...

3 Feb 19min

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1

Dr. Joshua Reuss is back on the podcast to discuss the full update to the living guideline on stage IV NSCLC without driver alterations. He discusses the new evidence and how this impacts the latest r...

3 Feb 18min

Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1

Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1

Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients...

20 Jan 13min

Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline

Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline

Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic ...

6 Jan 22min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
rss-jossan-nina
johannes-hansen-podcast
rss-vuxna-pa-latsas
not-fanny-anymore
rss-viktmedicinpodden
sexnoveller-deluxe
angestpodden
sova-med-dan-horning
sa-in-i-sjalen
brottarbroder
rss-real-talk-with-jesper-stahl
rss-basta-livet
rss-relationsrevolutionen
rss-sjalsligt-avkladd
tyngre-traningssnack
sag-det-bara
rss-hos-psykologen